Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review.

Josh WallshCharlotte Luths Haily Kil Ron P Gallemore

Published in: Clinical ophthalmology (Auckland, N.Z.) (2020)

Repeated DEX over extended follow-up offers significant anatomic benefits to all cohorts. Visual benefits are only seen in RVO, DME and select uveitis demographics.

Keyphrases

vascular endothelial growth factor
juvenile idiopathic arthritis
low dose
ankylosing spondylitis
high dose
diabetic retinopathy
soft tissue
age related macular degeneration
rheumatoid arthritis